Microcephaly
Gene: SETD2
PMID 32710489: 12 unrelated patients, ranging from 1 month to 12 years of age, with a multisystemic neurodevelopmental disorder associated with a specific de novo heterozygous mutation in the SETD2 gene (R1740W).
Key clinical features: severely impaired global development apparent from infancy, feeding difficulties with failure to thrive, small head circumference, and dysmorphic facial features. Affected individuals have impaired intellectual development and hypotonia; they do not achieve walking or meaningful speech. Other neurologic findings may include seizures, hearing loss, ophthalmologic defects, and brain imaging abnormalities. There is variable involvement of other organ systems, including skeletal, genitourinary, cardiac, and possibly endocrine.
Sources: LiteratureCreated: 14 Dec 2022, 7:08 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Rabin-Pappas syndrome,MIM# 620155
Publications
Gene: setd2 has been classified as Green List (High Evidence).
Gene: setd2 has been classified as Green List (High Evidence).
gene: SETD2 was added gene: SETD2 was added to Microcephaly. Sources: Literature Mode of inheritance for gene: SETD2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SETD2 were set to 32710489 Phenotypes for gene: SETD2 were set to Rabin-Pappas syndrome,MIM# 620155 Review for gene: SETD2 was set to GREEN